I stated numerous times on the old YMB that I believe INO is waiting for results on 3112 so that they may use it as an arm in their Phase3. The results of VGX 3100 were good but not great. This will be a 100 mil trial and I 'm not sure they are willing to go into it without info from 3112 and possibly include an arm in the Phase 3 or at least use the info in determining the trial design. We are coming up on 2.5 years now since initial readout - that is more than ample enough time to initiate a Phase3.
We will know in the next two months to see why this has been delayed as much as it has........jmho
PS.......if 3112 reads out well - maybe Medimmune could be induced to partner on the VGX 3100 trial. That's something that Kim would be willing to do considering the breadth of their pipeline now...